PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
AboutPricing
Drug ReportsContezolid
Contezolid
Contezolid is a small molecule pharmaceutical. It is currently being investigated in clinical studies.
Download report
Favorite
Events Timeline
Commercial
Clinical
Drug
Target
Variants
Financial
Trends
Safety
Events Timeline
5D
1M
3M
6M
YTD
1Y
2Y
5Y
Max
Events
FDA approval date
EMA approval date
Patent expiration date
Study first post date
Last update post date
Start date
Primary completion date
Completion date
Results first post date
Plot placeholder
Mock data
Subscribe for the real data
Commercial
No data
Clinical
Clinical Trials
10 clinical trials
View more details
Plot placeholder
Mock data
Subscribe for the real data
Indications Phases 4
No data
Indications Phases 3
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
InfectionsD007239EFO_0000544——21——3
Communicable diseasesD003141———21——3
TuberculosisD014376EFO_0000774A15-A19221——3
Diabetic footD017719EFO_1001459———1——1
Wound infectionD014946————1——1
Focal infectionD005490————1——1
Pulmonary tuberculosisD014397EFO_1000049A15——1——1
Indications Phases 2
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Bacterial infectionsD001424—A49—2———2
Bacterial skin diseasesD017192———2———2
Skin diseasesD012871—L00-L99—1———1
Gram-positive bacterial infectionsD016908———1———1
Osteoarticular tuberculosisD014394EFO_0007487A18.011———1
Meningeal tuberculosisD014390—A17.011———1
MeningitisD008581EFO_0000584G0311———1
Indications Phases 1
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Healthy volunteers/patients———3————3
PharmacokineticsD010599——2————2
Venous thromboembolismD054556EFO_0004286I741————1
ThromboembolismD013923——1————1
Indications Without Phase
No data
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
General
Drug common nameContezolid
INNcontezolid
Description
Contezolid (trade name Youxitai) is an antibiotic of the oxazolidinone class. It is effective against Staphylococcus aureus, methicillin-resistant Staphylococcus aureus (MRSA), Streptococcus pyogenes, Streptococcus agalactiae, and other bacteria.
Classification
Small molecule
Drug classoxazolidinone antibacterials
Image (chem structure or protein)Loading
Structure (InChI/SMILES or Protein Sequence)
O=C1C=CN(c2c(F)cc(N3C[C@H](CNc4ccon4)OC3=O)c(F)c2F)CC1
Identifiers
PDB—
CAS-ID1112968-42-9
RxCUI—
ChEMBL IDCHEMBL3287379
ChEBI ID—
PubChem CID25184541
DrugBankDB12796
UNII IDB669M62ELP (ChemIDplus, GSRS)
Target
No data
Variants
No data
Financial
No data
Trends
PubMed Central
Top Terms for Disease or Syndrome:
Plot placeholder
Mock data
Subscribe for the real data
Additional graphs summarizing 4,662 documents
View more details
Safety
Black-box Warning
No Black-box warning
Adverse Events
Top Adverse Reactions
Plot placeholder
Mock data
Subscribe for the real data
3 adverse events reported
View more details
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use